Company press releases and official corporate announcements.
A centralized feed of corporate press releases, earnings announcements, mergers, and official statements. Content is presented for informational purposes and may require additional analysis for market relevance.
12,947 total articles
Enlivex Ltd., a Nasdaq-listed quality longevity company, received a Nasdaq notification indicating its stock has fallen below the required $1.00 minimum bid price. The company has 180 days to raise its share price above the threshold or potentially face delisting, with possible options including a reverse stock split. The notice does not currently …
Expion360 Inc. announced its Q1 2026 financial results, showing a 24% decrease in sales compared to Q1 2025 mainly due to discontinuing low-margin accessories and inventory adjustments by OEM customers. Despite lower sales and higher operating expenses leading to a larger net loss, the company is expanding into the construction and industrial secto…
Outlook Therapeutics reported its fiscal Q2 2026 financial results, highlighting a net loss reduction compared to last year and progress in commercializing LYTENAVA™ (bevacizumab gamma) in Europe including a new partnership in Switzerland. The company completed a formal dispute resolution meeting with the FDA regarding its U.S. approval application…
Cerebras Systems Inc. has completed its initial public offering of 34.5 million Class A common shares at $185 each, raising approximately $6.38 billion in gross proceeds. The company's stock began trading on Nasdaq under the ticker CBRS. Cerebras specializes in AI infrastructure with its flagship Wafer-Scale Engine 3 processor, which is significant…
Solana Company (NASDAQ: HSDT) reported Q1 2026 revenue of $3.6 million primarily from staking rewards, a substantial increase from the previous year. Despite strong gross profits, the company reported a net loss of $99.8 million due to large non-cash unrealized digital asset losses and operational expenses. The company continued capital allocation …
Binah Capital Group, Inc. announced its first quarter 2026 results marked by a 12.9% increase in assets under management to $29.0 billion, a near doubling of net income to $1.9 million, and a 50% increase in EBITDA compared to the prior year period. Despite stable total revenues around $48.7 million, the company achieved higher profitability and st…
Covenant Logistics Group, Inc. announced a quarterly cash dividend of $0.07 per share for both Class A and Class B common stock, payable on June 26, 2026, to shareholders of record as of June 5, 2026. The dividend distribution aligns with the company's approved cash dividend program, though future dividends remain subject to board approval and fina…
Plus Therapeutics announced its first quarter 2026 financial results highlighting progress in its CNSide commercial expansion and REYOBIQ clinical development programs. The company secured FDA Orphan Drug Designation for REYOBIQ in pediatric malignant gliomas, expanded payer coverage for CNSide to approximately 81 million covered lives, and complet…
Candel Therapeutics reported extended phase 3 clinical trial results for its lead immunotherapy candidate, aglatimagene besadenovec (CAN-2409), in intermediate- to high-risk localized prostate cancer. After a median of 58 months follow-up, the therapy demonstrated a statistically significant 39% improvement in prostate cancer-specific disease-free …
Monster Beverage Corporation announced that its Board of Directors has authorized a new share repurchase program for up to $500 million, adding to approximately $400 million previously available. The repurchases will be executed at management's discretion based on market conditions, strengthening shareholder value and signaling confidence in the co…
Breeze Acquisition Corp. II, a Cayman Islands-incorporated blank check company, announced the closing of a $15 million over-allotment option following its initial public offering of 14 million units on the Nasdaq Global Market under the ticker BREZU. Each unit includes one ordinary share and one right, with securities expected to trade separately a…
Rani Therapeutics released its Q1 2026 financial results, highlighting progress in its Phase 1 clinical study of RT-114, an oral obesity treatment using its RaniPill® technology in collaboration with ProGen. The company appointed key strategic executives and announced a CFO transition while maintaining adequate cash to fund operations into late 202…
Hydrofarm Holdings Group, Inc. announced first quarter 2026 financial results with net sales down 29.6% year-over-year to $28.5 million, gross profit margin dropping to 6.4%, and a net loss of $14.6 million. The company is experiencing lower volume due to industry oversupply and has taken significant cost reduction measures including consolidating …
Materialise NV, a leader in 3D-printed medical devices and additive manufacturing software, will hold its Annual General Shareholders' Meeting on June 16, 2026. The company provides advanced 3D printing software and services to multiple industries globally and shares information on its website for shareholders.
PDF Solutions successfully closed an upsized underwritten public offering of 5.25 million shares at $44.00 per share, including the full exercise of the underwriters' greenshoe option. The company raised approximately $85.7 million in gross proceeds, strengthening its capital base to support ongoing growth in semiconductor data solutions.
Acrivon Therapeutics, a clinical-stage biotechnology company listed on Nasdaq, approved a stock option grant to incentivize a new employee, in compliance with Nasdaq Listing Rule 5635(c)(4). The options cover 111,150 shares with exercise price equal to the closing price on the grant date, and vest over time subject to continued employment. The anno…
Davis Commodities Limited announced fiscal year 2025 financial results, showing a 39.2% increase in revenue to $184.2 million driven by higher trading volumes in sugar and rice, primarily in Africa and China. Despite revenue growth, the company reported a net loss of $5.0 million due to elevated input costs, supply chain disruptions, and increased …
MacKenzie Realty Capital, Inc. announced its Q3 2026 financial results, showing significant improvement with a 27% increase in net revenues to $5.4 million and a return to positive funds from operations (FFO) of $308,040 compared to negative $3.2 million in the prior year. The company's Aurora at Green Valley development is now stabilized with over…
Regeneron Pharmaceuticals, Inc. sponsored the 2026 Regeneron International Science and Engineering Fair (ISEF), awarding over $7 million to high school students worldwide for innovative STEM projects. Hikaru Kuribayashi won the $100,000 top innovator award for his work on a simulation program related to complex folding. Other winners focused on env…
Luda Technology Group Limited (NYSE: LUD), a manufacturer and trader of stainless steel and carbon steel flanges and fittings, announced the completion and filing of its 2025 annual report on Form 20-F with the U.S. Securities and Exchange Commission. The company provides audited financial statements and highlights its over 20 years of operation in…
Medifast Inc. highlights the scientific validity of its OPTAVIA weight loss program, supported by over 18 randomized controlled trials and numerous peer-reviewed studies. Their program emphasizes preservation of lean mass and reduction of visceral fat, with coaching significantly improving weight loss outcomes over self-guided efforts. This peer-re…
Medifast's OPTAVIA program, supported by peer-reviewed research including 18 randomized controlled trials, demonstrates that structured meal replacement plans combined with coaching significantly reduce visceral fat and preserve lean muscle mass, which are critical for metabolic health. Clinical data highlights that coaching leads to substantially …
Alpha Modus Holdings, Inc. announced the resolution of its patent infringement lawsuit against Adroit Worldwide Media in the US District Court for the Central District of California. This settlement is part of Alpha Modus's broader patent enforcement campaign targeting real-time consumer behavior and retail media technology. The company emphasized …
ProKidney Corp. reported Q1 2026 financial results and business highlights, focusing on its Phase 3 PROACT 1 study enrolling patients with advanced chronic kidney disease (CKD) and type 2 diabetes. The company is on track to complete enrollment by mid-2026 and expects pivotal topline results in Q2 2027. Published positive Phase 2 data in a leading …
Toll Brothers, a leading US luxury home builder, announced Everstead, a new luxury townhome community in Cary, North Carolina. Featuring spacious, modern townhomes with personalization options, the community targets buyers seeking low-maintenance luxury living close to top schools and major employment hubs like Research Triangle Park. Sales are ant…
